£2.2M
Foresight Group led the investment round with participation from angel backers to support the expansion of the company radiology technology.
"We are very pleased to have closed this round following extraordinary levels of interest where we were oversubscribed. There has been an explosion of early stage healthtech funding across Europe, but we think that Hexarad has connected with investors because we are developing healthcare technology that truly addresses the biggest issues facing healthcare providers. Our first-hand experience of the pressure that radiology departments are under means that we are uniquely placed to develop innovative, clinically-led solutions"
H
Hexarad—London, UKForesight Group + 2 others